Plasma apelin: A novel biomarker for predicting diabetes

Wen Ya Ma, Tse Ya Yu, Jung Nan Wei, Chi Sheng Hung, Mao Shin Lin, Ying Jhu Liao, Dee Pei, Ching Chieh Su, Kuo Cheng Lu, Pi Hua Liu, Cheng Hsin Lin, Lee Ming Chuang, Hsien Li Kao, Jou Wei Lin, Ya Ju Chuang, Hung Yuan Li

研究成果: 雜誌貢獻文章

40 引文 斯高帕斯(Scopus)


Background: Apelin regulates insulin sensitivity and secretion in animals. However, whether plasma apelin predicts incident diabetes in humans remains unknown. Methods: We studied a cohort including 447 subjects (148 men, 299 women) without diabetes and followed for an average of 3. y. Diabetes was diagnosed by an oral glucose tolerance test, plasma hemoglobin A1c, and if the subject was taking medications for diabetes. Plasma apelin-12 at baseline was measured with a commercial kit. Results: Plasma apelin concentrations were higher in women than in men at baseline (p= 0.007). During follow-up, 43 subjects developed type 2 diabetes. Higher plasma apelin concentrations were associated with a higher risk of diabetes in men (p= 0.049) but not in women. Plasma apelin predicted incident type 2 diabetes in men (hazard ratio, 2.13, 95% CI 1.29-3.51, p

頁(從 - 到)18-23
期刊Clinica Chimica Acta
出版狀態已發佈 - 八月 5 2014


ASJC Scopus subject areas

  • Biochemistry
  • Clinical Biochemistry
  • Biochemistry, medical


Ma, W. Y., Yu, T. Y., Wei, J. N., Hung, C. S., Lin, M. S., Liao, Y. J., Pei, D., Su, C. C., Lu, K. C., Liu, P. H., Lin, C. H., Chuang, L. M., Kao, H. L., Lin, J. W., Chuang, Y. J., & Li, H. Y. (2014). Plasma apelin: A novel biomarker for predicting diabetes. Clinica Chimica Acta, 435, 18-23.